Karen J. Vigil - Concepedia

Author

Karen J. Vigil

The University of Texas Health Science Center at Houston

Also Known As

Anyelina Cantos, Divya Bhamidipati, K. J. Vigil, K. Vigil, K.J. Vigil, Karen J Vigil, Karen J. Vigil, Karen Joan Vigil, Karen Vigil, Karen J. Vigil

Publications

918

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at Houston The University of Texas MD Anderson Cancer Center Henry Ford Hospital Chiang Mai University

About

Karen J. Vigil is an author at The University of Texas Health Science Center at Houston specializing in medicine, infection control, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	193
2	Public Health	2	2	38
3	Epidemiology	2	2	38
4	Health Sciences	1	1	27
5	Diabetes	1	1	31

Karen J. Vigil

Publications

570

Citations

H-Index

Page 1

	Year	Citations
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation Roy F. Chemaly, Santosh Hanmod, Dhanesh B. Rathod, Blood	2012	115
<i>Escherichia coli</i>Pyomyositis: An Emerging Infectious Disease among Patients with Hematologic Malignancies Karen J. Vigil, James R. Johnson, Brian Johnston, Clinical Infectious Diseases	2009	72
A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries Roy F. Chemaly, Karen J. Vigil, Mustafa Saad, Cancer	2012	67
Analytic Review: Viral Pneumonias in Immunocompromised Adult Hosts Karen J. Vigil, Javier A. Adachi, Roy F. Chemaly Journal of Intensive Care Medicine Viral DiagnosticsRespiratory DiseasesImmunologyPediatricsRespiratory Infection	2010	35
Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus Kristen Marks, Minhee Kang, Triin Umbleja, Clinical Infectious Diseases	2023	33
Prevalence of Type 2 Diabetes Mellitus In Patients With Primary Hyperparathyroidism Monica G. Cardenas, Karen J. Vigil, Gary B. Talpos, Endocrine Practice UrologyDiabetesParathyroid HormoneType 2Parathyroid Disease	2008	31
Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012–2017) Mohanad Al‐Obaidi, Rodrigo Hasbun, Karen J. Vigil, Open Forum Infectious Diseases	2019	29
Multidrug-resistant Escherichia coli bacteremia in cancer patients Karen J. Vigil, Javier A. Adachi, Halim Aboufaycal, American Journal of Infection Control Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineMicrobiology	2009	27
Carbapenem-resistant Lactobacillus intra-abdominal infection in a renal transplant recipient with a history of probiotic consumption Jakapat Vanichanan, Violeta Chávez, Audrey Wanger, Infection ProbioticAntimicrobial SusceptibilityKidney TransplantProbiotic ConsumptionRenal Transplant Recipient	2016	26
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials Chloe Orkin, Jean‐Michel Molina, Pedro Cahn, The Lancet HIV First-line TherapyOpen-label ExtensionsAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2023	25

Page 1